0001493152-24-008613.txt : 20240301
0001493152-24-008613.hdr.sgml : 20240301
20240301182437
ACCESSION NUMBER: 0001493152-24-008613
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240301
DATE AS OF CHANGE: 20240301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cundy Kenneth C
CENTRAL INDEX KEY: 0001322959
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 24712164
MAIL ADDRESS:
STREET 1: 1455 ADAMS DRIVE, SUITE 2050
STREET 2: MENLO BUSINESS PARK
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
ownership.xml
X0508
4
2024-02-29
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001322959
Cundy Kenneth C
C/O ANEBULO PHARMACEUTICALS, INC.,
1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEVIEW,
TX
78734
0
1
0
0
Chief Scientific Officer
0
Stock Option (right to buy)
2.78
2024-02-29
4
A
0
72613
0
A
2034-02-28
Common Stock
72613
72613
D
The shares vest in a series of sixteen (16) equal quarterly installments on the first day of each calendar quarter, commencing with the first day of the calendar quarter beginning on April 1, 2024.
/s/ Kenneth C. Cundy
2024-03-01